Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105

Status:
Not yet recruiting

Trial end date:
2023-04-18

Target enrollment:

Participant gender:

this is an preventive study to evaluate the preventive effect of traditional chinese medicine TDX105 on Regorafenib induced Dermatologic Toxicities

Phase 2

Cancer Institute and Hospital, Chinese Academy of Medical Sciences